After the success of clinical trials in the country

“Health” authorizes the emergency use of a new vaccine against “Covid-19”

The Ministry of Health approved the manufacture and distribution of the vaccine by Hayat Bayutak.

From the source

The Ministry of Health and Community Protection announced the approval of the emergency use of the "new recombinant protein-based vaccine" from the company "Sinopharma CNPG", explaining that the decision comes after strict monitoring and evaluation of the data of the study that was conducted in the UAE.

The Ministry confirmed that this emergency use of the vaccine is in full compliance with the regulations and laws that allow for a faster review of licensing procedures, as part of the Ministry's comprehensive and integrated efforts in cooperation with health authorities to enhance the protection of community members from the "Covid-19" pandemic in the country.

The study included participants who were previously vaccinated with two doses of the inactive “Sinopharma CNPG” vaccine against “Covid-19”, where the seroconversion rate was recorded as 100% of neutralizing antibodies, and this was accompanied by high safety rates and the absence of serious side effects. All participants have.

The ministry explained that the vaccine showed an improved immune capacity against the mutants emerging from the “SARS-CoV-2” virus, with a high safety rate that allows rapid production and ease of storage and distribution, pointing out that the study conducted in the UAE showed an immune response against the emerging mutants of the virus, in volunteers. Those who previously received two doses of the inactive (Sinopharma CNPG) vaccine, stressing that the step reflects the strategy of the UAE in ensuring the priority of the health of community members and ensuring their safety, and its continuous efforts to combat the epidemic by all possible means.

The Ministry revealed its approval of the manufacture and distribution of the new vaccine by the "Hayat Biotech" company, which is the joint venture between "Sinopharma CNPG" and the "G42" company, where the vaccine will be available to the public as a booster dose from the beginning of the new year within the framework of the measures taken to contain The spread of the virus, at a time when reports indicate that the UAE is the largest country in the world with coverage of the “Covid-19” vaccine, as more than 22 million doses have been provided as of December 23.

• Manufacturing the new vaccine in the country, and distributing it as a booster dose as of the beginning of the new year.

Crossing to recovery

The Ministry of Health and Community Protection stated that the positive results achieved by the national campaign for the “Covid-19” vaccine, and the commitment of community members to obtain the vaccine, constitute an important stage in the face of the “Covid-19” virus to cross to recovery, so that life returns to normal and optimism and reassurance are enhanced in The community, while continuing to adhere to preventive health behaviors to preserve the gains and immunize the community from any mutated strains.

Follow our latest local and sports news and the latest political and economic developments via Google news